Speakers and Leaders by Track
Regulatory Track
Track Leaders
- Ronald Branning, VP Corporate Quality & Complianve, Gilead Sciences
- Paul D'Eramo, Executive Director, Johnson & Johnson
Session Leaders
- John Hannon, Principal, Computer Sys., Commissioning Agents Inc
- Charles Hoiberg, PhD, Executive Director, Pfizer
- James Vogel, PE, Principal, Process Facilities Services Inc
- Veda Walcott, Director of Quality, Cook Pharmica
Speakers
- Robert Baum, PhD, Executive Director, Pfizer Inc
- Ronald Branning, VP Corporate Quality & Complianve, Gilead Sciences
- Robert Brokamp, Dir Automation Services, Jacobs Engineering Group Inc
- Gail Burnett, PhD, Sr Dir, Quality Bioanalytical Dev, Genentech Inc
- Bruce Davis, Principal Consultant, Global Consulting
- Joseph Famulare, Senior Director, External Influence & Compliance, Genentech Inc
- John Groskoph, Director, New Products Group, Pfizer
- Reinhard Hanselka, PE, REA, Principal Chemical Engineer, IES
- Yukio Hiyama, PhD, Section Chief, Drugs Div, National Institute of Health Sciences
- William Huitt, Owner/President, W. M. Huitt Co.
- Steven Kozlowski, MD, Director, Office of Biotechnology, OPS, FDA
- Brian Lange, PE, Director - Quality Engineering, Merck & Co Inc
- Jacques Morenas, Assistant Director, AFSSAPS
- Moheb Nasr, PhD, Dir, Office of New Drug Quality, FDA/CDER/ONDQA
- Chinmoy Roy, Senior Automation Engineer, Genentech
- Brian Rubin, Process Engineer, CRB Engineers
- Thomas Schultz, PhD, Sr Director, Regulatory Sciences, Johnson & Johnson Pharma R&D LLC
- John Sever, President, Cascade Controls
- James Spavins, Vice President, Global CMC, Pfizer Inc
- Richard Zinkowski, Business Development Manager, Burkert Fluid Control Systems
Manufacturing Track
Track Leaders
- Larry Kranking, President, Aveta Lifesciences, USA
- Raymond Scherzer, Retired
Session Leaders
- Janice Abel, Principal Consultant
- Marc Abromovitz, CIH, Dir Global IH/ EHS Proj Eng, Johnson & Johnson
- Avril Balfrey, Senior Engineer, Amgen Inc
- Joseph Brower, Vice President, MKCS Inc
- Stephen Errico, PE, Director of Facilities Mgmt, Eisai Inc
- Igor Gonda, CEO and President, Aradigm Corp
- Jack Lysfjord, Principal Consultant, Lysfjord Consulting LLC
- Catherine Middelberg, Manager, Engineering, Wyeth Biotech
- Miriam Monge, VP Marketing & Disposables Implementation, Biopharm Services Ltd.
- Scott Sutton, PhD, Sr. Director, Microbiology Services, Vectech Pharmaceutical Consultants, Inc.
Speakers
- Tim Allers, CIH, Mgr, Worldwide Ind Hygiene, Johnson & Johnson
- Arthur Caruso, Senior Process Engineer, Merck & Co Inc
- Gary Cleary, PhD, President & CTO, Corium International, Inc.
- Neslihan DelaCruz, Principal Engineer, Amgen Inc
- Stephen Dinka, Assoc Dir, Corporate Engineering, Genentech
- Ruediger Dorn, Managing Director of the Worldwide Life Sciences Group, Microsoft
- Thomas Erdenberger, Senior Project Manager, Xcellerex, Inc.
- Adam Goldstein, Sr Mgr, Clinical Operations, Genentech
- Simon Holland, Director, Pharma Dev., GlaxoSmithKline
- Bradley Kosiba, PhD, Senior Director, Pfizer
- Akira Kusai, PhD, Senior Chief Researcher, Daiichi Sankyo Co Ltd
- YC Lee, PhD, Senior Director, PharmEng Innovations
- Stephen Perry, PMP, President, Kymanox
- Ernesto Renzi, Vice President, IMA Edwards
- Gilbert Salud
- Jeff Silverman, Vice President of Operations, Abraxis BioScience
- Andrew Sinclair, Managing Director, Biopharm Services Ltd
- Donald Singer, National Director, Divisions, American Society for Quality
- Robert Sussman, PhD, Managing Principal, SafeBridge Consultants, Inc.
- Radha Tirumalai, PhD, Senior Scientist, US Pharmacopeia
- Blair Tyson, Sr Manager Aseptic Operations, Eisai Inc
- Eric Unrau, Core Team Leader, CRB Consulting Engineers, Inc.
- Gary Ward, Mgr, Operational Excellence, Wyeth Biotech
- Dave Wareheim, Engineering Fellow, 1Davey Inc
- Hobert Williams, Mgr, Engineering & Capital Projects, Wyeth Laboratories
- Joe Wyse, PhD, President and CEO, Coldstream Laboratores, Inc.
Facilities Engineering Track
Track Leaders
- M. James Kimmel, Director of Engineering, Cephalon
- Thomas Trevithick, VP, Integrated Eng'g Mgmt, Wyeth
Session Leaders
- Sandro Bressi, Project Mgr/Lab Planner, Flad Architects
- Joseph De Paul, President, Skye Technical Services
- James Dolceamore, Director, R&D Eng'g, AstraZeneca Pharmaceuticals LP
- Daniel Franklin, Regional Mgr, Compliance Svcs, IPS
- Gerard Guillorn, Vice President, Structure Tone Inc.
- Terry Jacobs, AIA, Principal, Jacobs/Wyper Architects, LLP
- Steven Kennedy, PE, Vice President, Parsons
- Alex Konopka, Engineer Consultant, Eli Lilly & Co
- Chad Wachter, Biopharm Manager, GlaxoSmithKline
Speakers
- Patrick Banes, NE Technical Sales Mgr, Astro Pak Corp
- Anthony Bevilacqua, Director, Research/Development, Mettler-Toledo Thornton Inc
- Mark Butler, Senior Vice President, IPS
- Laura Carlson, Senior Associate, RMJM Hillier
- Nissan Cohen, Industry Sales Mgr, IN USA
- James Corry, Engineering Ldr, Process Maintenance, Eli Lilly & Co
- Daniel D'Aquila, PE, Director, Engineering & Validation, GlaxoSmithKline
- Jim Davis, Construction Manager, Jacobs Engineering Group Inc
- Katherine Detterline, Commissioning/LEED Admin, Bovis Lend Lease
- David Dolgin, Sr Quality Program Manager, Abbott Labs
- Ronald Eiswerth, Associate Principal, RMJM Hillier
- Roger Emmett, Director of Quality, NA, Praxair Distribution, Inc.
- Gerald Geisler, Director Global Eng, Bristol-Myers Squibb
- Michelle Gonzalez, BioPharm Engineering Consultant
- Robert Graves, AIA, LEED, AP, Chairman of the Board/Principal, Flad Architects
- Thomas Hartman, Vice President, GMP Operations, GlaxoSmithKline
- Gary Hedrick, Associate Eng Consultant, Eli Lilly and Company
- John Hercik, Quality Manager, Praxair, Inc.
- John Holton, PE, Director of Engineering, Cephalon
- Terry Jacobs, AIA, Principal, Jacobs/Wyper Architects, LLP
- Gary Knapick, P.E., Validation Manager, Bristol-Myers Squibb
- Chad Larrabee, Category Manager, Ingersoll-Rand
- Garrick Maine, Architect/Project Designer, Flad & Associates
- Maria Teresa Martinez, Northern Region Quality Mgr, Jacobs Engineering
- Paul Mathew, Staff Scientist, Lawrence Berkeley Nt'l Lab
- Dave McGlashan, RA
- John Murray, PE, Facilities Site Director, Bristol-Myers Squibb
- Reune Runyon, Global Key Account Manager, Christ Pharma and Life Sciences
- Christopher Savitz, Operational Excellence Leader, GlaxoSmithKline Biologicals
- N. Cameron Sipe, Principal Project Engineer, Wyeth Biotech
- Ed Walczak, Project Manager, AstraZeneca
- Paul Whitby, Consumer OpU Engineering, Maintenance & Capital Planning Leader, Wyeth
- David Wilson, Director, Engineering, Abbott Bioresearch Center
Innovation Track
Track Leaders
- David Selby, PhD, Managing Director, Selby Hope International Ltd
- Timothy Tyson, Chairman and CEO, Aptuit, Inc.
- Sion Wyn, Director, Conformity Ltd.
Session Leaders
- Gordon Farquharson, Principal, Critical Systems Ltd
- Donald Moore, PE, Engineering Consultant, Eli Lilly & Co
- Arthur Perez, PhD, Executive Expert, QA, Novartis Pharmaceuticals Corporation
- Robin Robinson, Director, HHS/OS/ASPR/BARDA
- David Selby, PhD, Managing Director, Selby Hope International Ltd
- Thomas Warf, Program Manager, HHS/BARDA
- Sion Wyn, Director, Conformity Ltd.
Speakers
- Winnie Cappucci, PS Compliance IT Sys NA, Bayer Healthcare
- Armen Donabedian, Sr. Program Manager, Vaccines, HHS/OS/ASPR/BARDA
- Norman Goldschmidt, Principal, VP Engineering, Genesis Engineers
- Dean Hale, Engineering Consultant, Eli Lilly & Co
- Robert Huebner, Senior Program Manager, HHS/OS/ASPR/BARDA
- Anthony Margetts, Consultant, Factorytalk Co., Ltd.
- Dan Milholland, Principal, Milholland & Associates
- David Petko, PE, Senior Director, Auxilium Pharmaceuticals, Inc.
- George Robertson, Principal, Tunnell Consulting
- Dustin Schafer, Mechanical Engineer, CRB Consulting Engineers Inc
- Sabra Seyer, Global PNS Director, Pfizer
- Ulla Thomsen, MSC Mechanical Engineering, Novo Nordisk A/S
Investigational Products Track
Track Leaders
- Michelle Foust, PharmD, Director, New Product Dev, Almac Clinical Services
- Paula Mastrangelo, Associate Director, Bristol-Myers Squibb
- Bernd Steffens, Global Head Clinical Trial Supplies Unit, Boehringer Ingelheim Pharma GmbH & Co
Session Leaders
- Kristen DeVito, Director of Operations, Aptuit Inc
- Michelle Foust, PharmD, Director, New Product Dev, Almac Clinical Services
- Julie Jacobs, Director Clinical Services, ALMAC
- Kunal Jaiswal, Director, Global Clinical Supply, Schering-Plough Corporation
- Michael Ku, PharmD, VP, Clinical Pharmacy Svcs, Genzyme Corp
- Paula Mastrangelo, Associate Director, Bristol-Myers Squibb
- Christine Milligan, Director, Client Services, Fisher Clinical Services Inc
- Bernd Steffens, Global Head Clinical Trial Supplies Unit, Boehringer Ingelheim Pharma GmbH & Co
- Michael Sweeney, Global Director, Strategic Development, World Courier, Inc.
Speakers
- Chedia Abdelkafi, Dir, Clinical Supplies Solutions, N-Side
- Dale Aldrich, President, Ultramikro, LLC
- Michael Arnold, RPh, Bus. Process Head, GSC, Pfizer Inc
- Dave Asher, CEO & President, Asher Associates Inc.
- Sandra Cook, PhD, Supply Chain Project Manager, AstraZeneca
- Patricia Dimock, Packaging Coordinator, Pfizer
- Kathleen Eddeh, Clinical Demand Project Mgr, Schering Plough Corporation
- Evelyn Ego, Head Global Clinical Supply, Bayer Schering Pharma AG
- Christine Fattore, Director, CRPS, MedImmune
- Miguel Feliz, Senior Clinical Supplies Manager, Schering-Plough Corp
- Dan Giang, Clinical Trials Pharmacist, Almac Clinical Services
- Mitchell Horoho, CT Materials Associate, Eli Lilly & Co
- Vickie Johnson, Clinical Trials Pharmacist, Almac Clinical Services
- Angus MacLeod, Global Depot Manager, Aptuit
- Linda Manor, RPh, Pharmacist, University of North Carolina Hospitals
- Michael McNear, VP Innovation Technologies, Fisher Clinical Services
- Alan Minsk, Partner & Leader, Food & Drug Practice Team, Arnall Golden & Gregory LLP
- Robert Pizzie, PhD, Senior Director, GCS Planning, Schering-Plough Research Institute
- Chris Popple, Mgr. Clinical Demand Planning, MedImmune
- Benjamin Romero, Principal Packaging Engineer, Bristol-Myers Squibb
- Robert Smith, Dir CPRS QA & QP, Genzyme Ltd
- Peter Trimboli, Drug Supply Manager, Bristol-Myers Squibb
Project Management Track
Track Leaders
- Peter Bigelow, Sr Vice President, Wyeth
- Andrew Skibo, Sr VP, Global Eng'g & Facilities, MedImmune
Session Leaders
- Deepak Agarwal, Director, Pharma Technology, Jacobs Consultancy
- Wayne Flaherty, President, Compliance Concepts International, Inc.
- Keith Gibbs, Corporate Manager, C&Q, Yonkers Industries
- Gerard Guillorn, Vice President, Structure Tone Inc.
- Terry Jacobs, AIA, Principal, Jacobs/Wyper Architects, LLP
- Gary Reichelt, PE, Principal, CRB Consulting Engineers, Inc.
- Wade Shelden, PE, VP Operations, Yonkers Industries Inc
- Sharad Sonde, The Metropolitan
Speakers
- Timothy Alsin, President, QSPEC Solutions Inc
- Charles Calitri, Vice President, Global Engineering, Pfizer
- Thomas Cappelle, Director, Americas Region, Abbott Laboratories
- Richard Ciccarelli, PhD, VP, Research Operations, Wyeth
- Bill Dodson, Consultant, Pharma-Tech Services, LLC
- Stephen Franey, RA, Senior Project Architect, IPS
- Martin Geukens, Director, Facilities & Engineering, Genzyme Flanders BVBA
- Mirko Hofmann, Senior Engineering Manager, Schering-Plough
- M. James Kimmel, Director of Engineering, Cephalon
- Sam Missimer, Senior Daylighting Specialist, Advanced Glazings LTD
- Brian Morrissey, Sr.Project Engineer, Merck & Co Inc
- Richard Priester, Principal, Strategic Facility Planning LLC
- Jonathan Sheh, Director, Project Manager, Johnson & Johnson
- Andrew Signore, PE, CPIP, CEO, IPS
- Andrew Skibo, Sr VP, Global Eng'g & Facilities, MedImmune
- Patricia Stewart-Flaherty, M.Sc., CQA, Senior Advisor, Regulatory and Quality Affairs, Dept Health & Human Serv ASPR/BARDA
- Kersey Vakharia, Senior Director Corp Eng, AstraZeneca
- Carlos Villalobos, Sr Director Global Engineering, Bristol-Myers Squibb
Guides Track
Track Leaders
- Brian Lange, PE, Director - Quality Engineering, Merck & Co Inc
- Gert Moelgaard, Vice President, Consulting, NNE Pharmaplan
Session Leaders
- Charles Calitri, Vice President, Global Engineering, Pfizer
- Pedro Dominguez, President, BlueVector, Inc.
- Carole Kuzian, PE, Senior Building Design Principal, CE&IC Inc
- Robert Lennon, Principal Engineer, Commissioning Agents Inc
- Linda McBride, RPh, RAC, VP, Regulatory Operations, InterMune, Inc.
- Patricia Melton, BSc, PhD, MBA, Managing Director, MIME Solutions Ltd
- John Nichols, Retired
- David Petko, PE, Senior Director, Auxilium Pharmaceuticals, Inc.
- Werner Seiferlein, PH/DE, Director, Project & Technology, Sanofi Aventis Deutschland GmbH
- Sabra Seyer, Global PNS Director, Pfizer
- Stephen Yu, Principle Process Engineer, BE&K - Delaware
Speakers
- John Robert Adamson, Mgr Compliance & Validation, Foster Wheeler Energy Ltd
- Joerg Block, PS-TS-KM-Tech Compliance, Bayer HealthCare AG
- Thomas Cappelle, Director, Americas Region, Abbott Laboratories
- Robert Chew, PE, President, Commissioning Agents, Inc.
- Peter Christensen, CPIP, Quality Professional, NNE Pharmaplan A/S
- Michael DeBellis, Lead Process Mech Engineer, Jacobs Engineering Group Inc
- Richard Denk, Director, Pharma Dept, Hecht Technologie GmH/ Kmpt AG
- Petter Gallon, Risk Analyst, AstraZeneca AB
- Paul Gerard, Sr Mechanical Engineer, Delaware Eng'g & Design Co
- Rick Gunyon, Quality Eng Consultant, Eli Lilly & Co
- Gary Johnson, Consultant, Workplace Exposure Solutions LLC
- Lori Kim, Manager, GPO Engineering, Abbott Laboratories
- Robert Lennon, Principal Engineer, Commissioning Agents Inc
- Tulsa Scott, Regional Manager, Commissioning Agents
- Nancy St Laurent, CPP, Sr Supervisor Process Eng, Parsons
- Mark Wessel, Sr Mgr, Global Eng'g Business Processes, Pfizer Inc.
- Steven Wisniewski, Sr Assoc Director of Compliance, IPS
- Graham Wrigley, PhD, Senior Mgr/Team Leader, Pfizer
- Stephen Yu, Principle Process Engineer, BE&K - Delaware
Notice Regarding Speakers
Speakers selected to present programs are
leading professionals in their field. However, in
rare circumstances, it may be necessary to make
substitutions. Every possible effort will be made to secure a
speaker with comparable qualifications. Agendas are
subject to change without notice. Every precaution
is taken to ensure accuracy, but ISPE cannot accept
responsibility for information distributed or contained
in the programs or for any opinion expressed.
